Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12 abstracts have been ...
"At Catalyst, everything begins with patients. Our presence at these scientific meetings reflects our ongoing commitment to advancing differentiated therapies that can meaningfully impact the lives of ...
Following the event, a copy of the poster presentations will be available on the Company’s website at: https://prokidney.com/our-technology/publications/ Additional information on ASN Kidney Week 2025 ...
HanchorBio, a clinical-stage biotechnology company focusing on immune-oncology and dedicated to developing next-generation multi-specific immunotherapies, today announced that an abstract detailing ...
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...
Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.
Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea LivaNova PLC (Nasdaq: ...
The oral and scientific poster presentations feature the research of independent investigators: Thurs., Oct. 9, from 11 a.m.-12 p.m. EDT during Research Abstracts Phenotypical Trajectories of Subjects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback